Wijnker et al. demonstrated that MyBPC3 mutations could affect oxidative stress and were associated with diastolic dysfunction, fibrosis, cardiac hypertrophy, and arrhythmias, which are all hallmarks of HCM (44). The gene discussed is MYBPC3; the disease is Arrhythmia.